You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JAZZ Sale Disclosure
Smith Mark Douglas · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$266.75K
Smith Mark Douglas Director
JAZZ
Jazz Pharmaceuticals
JAZZ
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
JAZZ daily price context
Close on/before transaction
$230.59
Jun 15, 2026
First close after public filing
$224.66
Jun 18, 2026
30-day return after filing
+10.18%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 1,157 shares @ $230.55
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001756253-26-000004
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$266.75K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Jazz Pharmaceuticals Plc JAZZ Current | Sale | Jun 15, 2026 | $266.75K |